Related Experiment Video
Updated: May 1, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
2.6K
Telemedicine for adolescents with type 1 diabetes
Jennifer P Dougherty1, Terri H Lipman2, Sandra Hyams3
1The Children's Hospital of Philadelphia, PA, USA jpdougherty@alumni.upenn.edu.
Western Journal of Nursing Research
|April 4, 2014
Summary
Telemedicine offers potential for adolescent diabetes management but requires more research. Current studies show inconsistent results, highlighting the need for technological advancement to improve health outcomes and prevent long-term diabetes complications.
Area of Science:
- Pediatric Endocrinology
- Digital Health
- Chronic Disease Management
Background:
- Diabetes is a prevalent chronic condition in children and adolescents.
- Managing diabetes in adolescents poses unique challenges for healthcare providers.
- Adolescent health requires tailored interventions for effective chronic disease management.
Purpose of the Study:
- To define telemedicine and its applications in healthcare.
- To review existing telemedicine intervention studies for adolescents with diabetes.
- To interpret findings within the current healthcare landscape and guide future practice.
Main Methods:
- Literature review of telemedicine intervention studies focused on adolescent diabetes.
- Analysis of study outcomes in the context of current healthcare trends.
- Educational synthesis for clinicians and researchers on adolescent needs and telemedicine.
Main Results:
- Telemedicine interventions for adolescent diabetes management have not yet shown consistent, significant positive outcomes.
- Existing research indicates a need for further investigation into effective telemedicine strategies.
- The current application of telemedicine in this population requires refinement.
Conclusions:
- Telemedicine holds promise for improving adolescent diabetes care but requires further development.
- Continued research and technological innovation are essential for enhancing diabetes control.
- Effective telemedicine use can help prevent long-term complications associated with adolescent diabetes.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
01:12Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:16Insulin: Dosing Regimen and Adverse Effects
1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
01:19Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17